Anakinra for COVID-19 Respiratory Symptoms
Condition(s):COVID-19 Infection; ANAKINRA Treatment; Optimized Standard of Care (oSOC)Last Updated:January 15, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19 Infection; ANAKINRA Treatment; Optimized Standard of Care (oSOC)Last Updated:January 15, 2021Terminated
Condition(s):Acute Myocardial Infarction; Heart FailureLast Updated:May 23, 2016Completed
Condition(s):Kawasaki DiseaseLast Updated:February 28, 2024Recruiting
Condition(s):Still’s Disease, Adult-Onset; Still’s Disease, Juvenile-OnsetLast Updated:June 30, 2021Terminated
Condition(s):Post-Acute COVID-19 Syndrome; Post-Acute COVID-19; Long COVIDLast Updated:February 28, 2024Recruiting
Condition(s):Familial Mediterranean FeverLast Updated:July 21, 2017Completed
Condition(s):Kawasaki DiseaseLast Updated:January 18, 2024Active, not recruiting
Condition(s):Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Relapsed Non Hodgkin Lymphoma; Neurotoxicity; Neurotoxicity Syndromes; Cytokine Release SyndromeLast Updated:March 7, 2024Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:January 27, 2021Completed
Condition(s):Hidradenitis SuppurativaLast Updated:May 27, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.